These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25608413)

  • 1. ['Men are not dying with, but from prostate cancer'].
    Stief C
    MMW Fortschr Med; 2014 Dec; 156(21-22):66. PubMed ID: 25608413
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():703-8. PubMed ID: 11037488
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search for better prognostic factors for men treated for localized prostate cancer continues.
    Karakiewicz PI; Suardi N; Shariat SF
    Eur Urol; 2008 Apr; 53(4):689-90. PubMed ID: 18093722
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.
    Chun FK; Epstein JI; Ficarra V; Freedland SJ; Montironi R; Montorsi F; Shariat SF; Schröder FH; Scattoni V
    Eur Urol; 2010 Dec; 58(6):851-64. PubMed ID: 20884114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could prostate biopsies be avoided in men older than 75 years with raised PSA?
    Nomikos M; Mariappan P; Zachou A; McNeill A; Bollina PR
    Urol Int; 2010; 85(4):410-4. PubMed ID: 20962505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
    Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
    J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.
    D'Amico AV; Cote K; Loffredo M; Renshaw AA; Chen MH
    J Urol; 2003 Apr; 169(4):1320-4. PubMed ID: 12629352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gleason scoring system faces change and debate.
    Schmidt C
    J Natl Cancer Inst; 2009 May; 101(9):622-9. PubMed ID: 19401555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostate cancer: increase information exchange!].
    Aktuelle Urol; 2013 May; 44(3):172. PubMed ID: 23712267
    [No Abstract]   [Full Text] [Related]  

  • 12. Can we accurately identify men with low risk prostate cancer?
    Neal DE
    J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostatic carcinoma: current status of diagnostic imaging].
    Bloch BN; Helbich T; Heinz-Peer G
    Wien Med Wochenschr Suppl; 2002; (113):89-91. PubMed ID: 12621851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
    Cohen SP; Jaskulsky SR
    Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer].
    Hefermehl L; Elke B; Sulser T
    Praxis (Bern 1994); 2010 Feb; 99(3):149-56, 158; quiz 157. PubMed ID: 20127633
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for the diagnosis and therapy of prostate cancer].
    Langkopf B
    Z Urol Nephrol; 1989 Apr; 82(4):221-5. PubMed ID: 2741566
    [No Abstract]   [Full Text] [Related]  

  • 17. Decision-making in clinically localized prostate cancer: evaluating and communicating risks.
    Sartor O
    Clin Genitourin Cancer; 2008 Sep; 6(2):63-4. PubMed ID: 18824426
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
    Forman JD; Lee WR; Roach M; Perez CA; Beyer DC; Blasko JC; Hussey DH; Paryani SB; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1373-82. PubMed ID: 11037553
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.